EI
ECO INNOVATION GROUP, INC. (ECOX)·Q2 2022 Earnings Summary
Executive Summary
- Q2 2022 revenue rose 167% sequentially to $311,156, turning gross profit positive, while net income of $1.95M was driven primarily by a $2.90M non-cash derivative gain; operating loss remained ($352,715) .
- Construction division continued to scale; current assets increased 227% YoY to $471k, with accounts receivable over $275k, supporting near-term cash collections .
- Financing optionality improved via a new up to $10M equity line of credit intended to retire toxic notes and fund commercialization of the patented Advanced GET extraction system now in prototype phase two .
- No formal quantitative guidance or earnings call was provided; shares authorized were raised to 5.0B on June 9, 2022, expanding issuance capacity .
What Went Well and What Went Wrong
What Went Well
- Revenues increased 167% QoQ to $311,156; management highlighted gross profit turning positive and resilient operations despite macro headwinds .
- Strengthening balance sheet indicators: current assets grew to $471,129 (+227% YoY), with accounts receivable at $275,913 (potential cash inflow) .
- Strategic progress: secured full patent protection for Advanced GET and moved to prototype phase two; “Q2 was a turning point quarter… we work towards commercial launch” — Julia Otey‑Raudes (CEO) .
What Went Wrong
- Core operations still loss-making: operating loss ($352,715); bottom-line profitability depended on a large non-cash derivative gain ($2,898,359) rather than recurring earnings .
- Working capital deficit persisted ($4,647,942), underscoring near-term liquidity risk despite improved financing access .
- No quantitative guidance or earnings call to clarify trajectory and milestones; limited disclosure on segment mix or margin drivers beyond construction commentary .
Financial Results
Notes:
- YoY context: Q2 2021 revenue was $0 and basic EPS was $(0.01), highlighting early-stage ramp versus prior year .
- No S&P Global Wall Street consensus estimates were available for ECOX; “vs estimates” comparison not possible.
KPIs and Balance Indicators
Guidance Changes
Earnings Call Themes & Trends
No earnings call transcript was available for Q2 2022. Themes synthesized from filings and press releases:
Management Commentary
- “We continue to drive toward scalable growth as we bring our innovation pipeline toward commercial phase operations… our construction division has been a productive source of top- and bottom-line growth…” — Julia Otey‑Raudes, CEO .
- “Q2 was a turning point quarter… milestones ahead as we work towards commercial launch of our… patented Advanced GET system.” — Julia Otey‑Raudes .
- “The line of credit will… retire outstanding toxic convertible financing notes… and push current projects toward commercialization.” — Equity line release .
Q&A Highlights
No Q2 2022 earnings call or Q&A was filed; no analyst Q&A clarifications were available [ListDocuments earnings-call-transcript returned none].
Estimates Context
No S&P Global Wall Street consensus EPS or revenue estimates were available for ECOX’s Q2 2022 given its microcap OTC profile; comparisons to estimates are unavailable (we attempted retrieval; none returned) [GetEstimates error log].
Key Takeaways for Investors
- Sequential acceleration: construction-driven revenue ramp (to $311k) and first positive gross profit, but operations remain loss-making; bottom-line strength was primarily non-cash (derivative gain) rather than recurring profitability .
- Liquidity trajectory: working capital deficit persists ($4.65M) despite stronger current assets; cash declined QoQ; accounts receivable build suggests near-term collections could help .
- Capital structure risk: derivative liabilities fell markedly in Q2 (to $1.72M) from Q1 ($5.77M), aided by conversions and valuation changes; the $10M equity line is a catalyst if used to retire toxic notes and stabilize capital structure .
- IP-led optionality: Advanced GET patent and prototype progress create optional future revenue streams; near-term execution remains construction-led while GET commercialization milestones develop .
- Share supply increased: authorized shares raised to 5B (effective June 9); expect potential issuance under the equity line; monitor dilution versus debt retirement and growth funding .
- Near-term trade: stock may react to additional construction wins, GET prototype updates, and concrete actions retiring toxic debt; absence of formal guidance and call keeps narrative sensitive to filings and press flow .